Laboratory of Molecular Biophysics Laboratory Journal 2001 Prof. L. N. Johnson

Previous: Electron microscopy of DNA scaffolds, Up: Protein Kinases, Return to: Contents.

Acknowledgments and References

Acknowledgements.

We thank the beam line scientists at SRS, ESRF and Elettra for their support with the synchrotron radiation measurements. We are grateful to our colleagues especially Jane Endicott, Martin Noble, Elspeth Garman, Tom Davies, Minakshi Ghosh, Julie Tucker and Jasper van Thor for their help and advice and to Richard Bryan for computing support. This work is supported by the MRC, the BBSRC, and the Oxford Centre for Molecular Sciences.

References.

Alexandru, G., Uhlmann, F., Mechtler, K., Poupart, M.-A. and Nasmyth, K. (2001). Phosphorylation of the cohesin subunit Scc1 by Polo/Cdc5 kinase regulates sister chromatid separation in yeast. Cell 105: 459-472.

Brown, N. R., Noble, M. E. M., Endicott, J. A., Garman, E. F., Wakatsuki, S., Mitchell, E. P., Rasmussen, B., Hunt, T. and Johnson, L. N. (1995). The crystal structure of cyclin A. Structure 3: 1235-1247.

Brown, N. R., Noble, M. E. M., Endicott, J. A. and Johnson, L. N. (1999). The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nature Cell Biology 1: 438-443.

Chen, P., Luo, C., et al. (2000). The 1.7Å crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. Cell 100: 681-692.

Garrett, S., Barton, W. A., Knights, R., Jin, P., Morgan, D. O. and Fisher, R. P. (2001). Reciprocal activation by cyclin dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop. Mol. Cell. Biol. 21: 88-99.

Graves, P. R., yu, L., Schwarz, J. K., Gales, J., Sausville, E. A., O'Connor, P. M. and Piwnica-Worms, H. (2000). The chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem. 275: 5600- 5605.

Harris, J. R. and Scheffler, D. (2002). Routine preparation of air dried negativley stained and unstained specimens on holey carbon films: a review of applications. Micron In press.

Hayashi, N., Matsubara, M., Takasaki, A., Titani, K. and Taniguchi, H. (1998). An expression system of calmodulin using T7 phage promoter in Escherichia coli. Protein Expression and Purification 12: 25-28.

Kawakami, K., Futami, H., Takahara, J. and Yamaguchi, K. (1996). UCN-01, 7- hydroxystaurosporine, inhibits kinase activity of cyclin dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem. Biophys. Res. Commun. 219: 778- 783.

Lawrie, A. M., Noble, M. E. M., Tunnah, P. R., Brown, N. R., Johnson, L. N. and Endicott, J. A. (1997). Protein kinase inhibition by staurosporine: details of the molecular interaction determined by X-ray crystallographic analysis of a CDK2- staurosporine complex. Nature Structural Biology 4: 796-801.

Lawrie, A. M., Tito, P., Hernandez, H., Brown, N. R., Robinson, C. V., Endicott, J. A., Noble, M. E. M. and Johnson, L. N. (2001). Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells. Protein Expression and Purification In press.

Lowe, E. D., Noble, M. E. M., Skamnaki, V. T., Oikonomakos, N. G., Owen, D. J. and Johnson, L. N. (1997). The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition. EMBO J. 16: 6646-6658.

Morgan, D. O. (1997). Cyclin-dependent kinases: engines, clocks and microprcessors. Annu. Rev. Cell. Dev. Biol. 13: 261-291.

Nigg, E. (1998). Polo-like kinases: positive regulators of cell division from start to finish. Current Opinion in Cell Biology 10: 776-783.

Pavletich, N. P. (1999). Mechanisms of cyclin dependent regulations: structures of cdks, their cyclin activators, and cip and INK4 inhibitors. J. Mol. Biol. 287: 821-828.

Sausville, E. A., Arbuck, S. G., et al. (2001). Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms. J. Clin. Oncol. 19: 2319-2333.

Senderowicz, A. M. and Sausville, E. A. (2000). Preclinical and clinical development of cyclin-dependent kinase modulators. J. Nat. Cancer Institute 92: 376-387.

Shapiro, G. I. and Harper, J. W. (1999). Anticancer drug targets: cell cycle and checkpoint control. J. Clin. Invest. 104: 1645-1653. Skamnaki, V. T., Owen, D. J., Noble, M. E. M., Lowe, E. D., Lowe, G., Oikonomakos,

N. G. and Johnson, L. N. (1999). The catalytic mechanism of phosphorylase kinase probed by mutational studies. Biochemistry 38: 14718-14730.

Song, H., Hanlan, N., Brown, N. R., Noble, M. E. M., Johnson, L. N. and Barford, D. (2001). Phospho-protein/protein interactions: the crystal structure of Kinase Associated Phosphatase (KAP) in complex with CDK2. Molecular Cell 7: 615- 626.

Toyoshima-Morimoto, F., Tanguchi, E., Shinya, N., Iwanatsu, A. and Nishida, E. (2001). Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature 410: 215-220.

Trewella, J., Blumenthal, D. K., Rokop, S. E. and Seeger, P. A. (1990). Small-angle scattering studies show distinct conformations of calmodulin in its complexes with two peptides based on the regulatory domain of the catalytic subunit phosphorylase kinase. Biochemistry 29: 9316-9324.

Wang, Q., Fan, S., Eastman, A., Worland, P. J., Sausville, E. A. and O'Connor, P. M. (1996). UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J. Nat. Cancer. Inst. 88: 956-965.

Winfree, E., Liu, F., Wenzler, L. A. and Seeman, N. C. (1998). Design and self-assembly of two-dimensional DNA crystals. Nature 394: 539-544.

Yurke, B., Turberfield, A. J., Mills, A. P., Simmel, F. C. and Neumann, J. L. (2000). A DNA fuelled molecular machine made of DNA. Nature 406: 605-608.

Previous: Electron microscopy of DNA scaffolds, Up: Protein Kinases, Return to: Contents.